ATC Group: D05AX06 Roflumilast

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D05AX06 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D05 Antipsoriatics
3 D05A Antipsoriatics for topical use
4 D05AX Other antipsoriatics for topical use
5 D05AX06

Active ingredients in D05AX06

Active Ingredient Description
Roflumilast

Roflumilast is a PDE4 inhibitor, a non-steroid, anti-inflammatory active substance designed to target both the systemic and pulmonary inflammation associated with COPD.